Salofalk is a brand name for a medication that contains the active ingredient mesalazine (also known as mesalamine or 5-aminosalicylic acid). It is primarily used in the treatment and management of inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease. Salofalk works by reducing inflammation in the colon and rectum, helping to control symptoms such as diarrhea, rectal bleeding, and abdominal pain. It is available in various forms, including tablets, granules, suppositories, and enemas, allowing for targeted treatment depending on the location and severity of the inflammation. Salofalk is often prescribed as part of a long-term management plan for individuals with IBD, aiming to induce and maintain remission of the disease.